Evidence map›Paper›PMID 42156524›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2026

Metabolic and body composition shifts after adrenalectomy in unilateral primary aldosteronism.

Yuanyuan Hu, Riqiang Bao, Cui Zhang, Yashu Zhu, Rui Xu, Chong Gao, Yuhan Guo, Yixiang Hu, Guang Ning, Shijia Pan and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuanyuan Hu *Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Riqiang Bao *Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Cui ZhangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Yashu ZhuShanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Rui XuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Chong GaoDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Yuhan GuoDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Yixiang HuShanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Guang NingDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Shijia PanShanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China. psj30691@rjh.com.cn.
Yiran JiangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China. jyr11662@rjh.com.cn.
Weiqing WangDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China. wqingw@shsmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primary objective of this prospective cohort study was to assess changes in energy metabolism and body composition following unilateral adrenalectomy in patients with unilateral primary aldosteronism (UPA). Patients with UPA undergoing adrenalectomy were enrolled and underwent standardized evaluations before surgery and at a 3-month postoperative follow-up. 24-h energy metabolism and body composition were measured using whole-room indirect calorimetry and dual-energy X-ray absorptiometry (DXA), respectively. At 3 months after surgery, mean 24-h energy expenditure decreased from 1923.67 ± 378.85 to 1851.71 ± 353.90 kcal/day (P = 0.0063). Carbohydrate oxidation declined from 136.87 ± 29.75 to 122.53 ± 33.37 g/day (P = 0.013), whereas protein oxidation increased from 62.82 ± 17.51 to 70.09 ± 14.55 g/day (P < 0.001). Postoperative body composition showed a reduction in lean mass (44.70 ± 10.31 to 43.54 ± 10.44 kg; P < 0.001), an increase in fat mass (20.45 ± 6.76 to 21.15 ± 6.41 kg; P = 0.026), and a rise in body fat percentage (29.96 ± 5.36% to 31.36 ± 5.04%; P < 0.001). Body weight did not change significantly (p = 0.25). Concurrently, insulin sensitivity indices also changed, with a lower Matsuda index (P = 0.0010) and Quantitative Insulin Sensitivity Check Index (QUICKI) (P = 0.0098), and higher Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) (P = 0.015). Unilateral adrenalectomy in patients with UPA is associated with a shift in postoperative metabolic phenotype, characterized by altered energy metabolism, body composition as well as insulin sensitivity. These findings underscore the need for individualized postoperative metabolic monitoring in this population.

Indexed as

AdrenalectomyBody CompositionEnergy MetabolismHyperaldosteronismAdultFemaleHumansInsulin ResistanceMaleMiddle AgedProspective StudiesAdrenalectomyEnergy metabolismInsulin sensitivityObesityPrimary aldosteronism

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.